We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Norwegian (NCLH) Extends Voyage Suspension to Meet CDC Guidelines
Read MoreHide Full Article
In a bid to meet the guidelines issued by the U.S. Centers for Disease Control and Prevention (CDC), Norwegian Cruise Line Holdings Ltd. (NCLH - Free Report) recently announced extension of voyage suspension for its Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands till Apr 30, 2021. Earlier, the company suspended all cruises through Feb. 28 and select cruises through March 31.
The company stated that its association with global government, public health authorities and Healthy Sail Panel expert advisors are likely to continue to ensure necessary measures to protect its guests, crew and the communities visited.
However, for cancelled cruises, guests are likely to be notified through travel advisors.
Increased Focus on Counter Measures
During the third-quarter 2020, the company collaborated with Royal Caribbean Cruises Ltd. (RCL - Free Report) to form the “Healthy Sail Panel”. The panel provided 74 specific recommendations (that includes a combination of science-backed protocols and procedures) to help reduce any risk out of the coronavirus pandemic. This includes COVID-19 testing of all guests and crew, application of face masks, physical distancing requirements and controlled shore excursions.
Going forward, the company anticipates that the cumulative effect of testing coupled with other protection measures at different phases of the cruise journey will significantly mitigate the risk. Also, it intends to continuously evaluate, refine and improve upon these protocols to offer a safe sailing.
Price Performance
Shares of Norwegian have surged 68.9% in the past six months compared with the industry’s 35.9% growth. Although, the cruise industry is witnessing dismal demand for cruise due to coronavirus-induced shutdowns, the company’s load factor for second half of 2021 and 2022 are within the company’s historical range. This along with initiatives to expand its fleet size are encouraging. Meanwhile, earnings estimates for 2021 have moved up in the past 30 days depicting analysts’ optimism regarding the stocks’ growth potential.
A better-ranked stock in the same space is Cedar Fair, L.P. (FUN - Free Report) , which carries a Zacks Rank #2 (Buy).
Cedar Fair’s 2021 earnings are expected to surge 77.1%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Norwegian (NCLH) Extends Voyage Suspension to Meet CDC Guidelines
In a bid to meet the guidelines issued by the U.S. Centers for Disease Control and Prevention (CDC), Norwegian Cruise Line Holdings Ltd. (NCLH - Free Report) recently announced extension of voyage suspension for its Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands till Apr 30, 2021. Earlier, the company suspended all cruises through Feb. 28 and select cruises through March 31.
The company stated that its association with global government, public health authorities and Healthy Sail Panel expert advisors are likely to continue to ensure necessary measures to protect its guests, crew and the communities visited.
However, for cancelled cruises, guests are likely to be notified through travel advisors.
Increased Focus on Counter Measures
During the third-quarter 2020, the company collaborated with Royal Caribbean Cruises Ltd. (RCL - Free Report) to form the “Healthy Sail Panel”. The panel provided 74 specific recommendations (that includes a combination of science-backed protocols and procedures) to help reduce any risk out of the coronavirus pandemic. This includes COVID-19 testing of all guests and crew, application of face masks, physical distancing requirements and controlled shore excursions.
Going forward, the company anticipates that the cumulative effect of testing coupled with other protection measures at different phases of the cruise journey will significantly mitigate the risk. Also, it intends to continuously evaluate, refine and improve upon these protocols to offer a safe sailing.
Price Performance
Shares of Norwegian have surged 68.9% in the past six months compared with the industry’s 35.9% growth. Although, the cruise industry is witnessing dismal demand for cruise due to coronavirus-induced shutdowns, the company’s load factor for second half of 2021 and 2022 are within the company’s historical range. This along with initiatives to expand its fleet size are encouraging. Meanwhile, earnings estimates for 2021 have moved up in the past 30 days depicting analysts’ optimism regarding the stocks’ growth potential.
Zacks Rank & Key Pick
Norwegian — which shares space with Carnival Corporation & Plc (CCL - Free Report) in the Zacks Leisure and Recreation Services industry — has a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
A better-ranked stock in the same space is Cedar Fair, L.P. (FUN - Free Report) , which carries a Zacks Rank #2 (Buy).
Cedar Fair’s 2021 earnings are expected to surge 77.1%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>